Henderson Michael Thomas
CIK 0001779990
Chief Executive OfficerDirector
Filings
29
Latest May 29, 2026
Issuers covered
3
Showing
29 of 29
Page 1
Track record
40 of 46 open-market trades scored (87% price coverage) - 6 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 40 | 45% | -1.4% | -2.5% | +19.3% | -22.0% |
| 90 days | 34 | 44% | -1.8% | -4.5% | +41.6% | -49.5% |
| 180 days | 22 | 64% | +5.4% | +5.6% | +33.6% | -31.7% |
| 365 days | 17 | 53% | -21.2% | +6.5% | +29.6% | -125.6% |
Issuers
Companies where Henderson Michael Thomas has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | 22 | May 15, 2026 |
| SYRE | Spyre Therapeutics, Inc. | 6 | May 29, 2026 |
| ARYD | Arya Sciences Acquisition Corp IV | 1 | Jul 31, 2024 |
All filings
29 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|